VIR BIOTECHNOLOGY, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • November 10th, 2020 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2020 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between Vir Biotechnology, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
VIR BIOTECHNOLOGY, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 10th, 2020 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2020 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between Vir Biotechnology, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
VIR BIOTECHNOLOGY, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 10th, 2020 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2020 Company Industry JurisdictionVir Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
VIR BIOTECHNOLOGY, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 10th, 2020 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2020 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between Vir Biotechnology, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).